Research Article
End-Stage Kidney Failure in Oman: An Analysis of Registry Data with an Emphasis on Congenital and Inherited Renal Diseases
Table 5
Inherited kidney diseases in ESKD population (2001–2015).
| Inherited kidney disease | Number | Proportion of inherited kidney disease (%) | Proportion of ESRD in this cohort (%) | Age group () | 0–12 | 13–19 | 20–44 | 45+ |
| Autosomal dominant polycystic kidney disease (ADPKD) | 56 | 40.3 | 2 | 1 | 1 | 17 | 37 | Congenital anomalies of kidney and urinary tract (CAKUT) | 16 | 11.5 | 0.6 | 8 | 6 | 2 | 0 | Alport syndrome | 13 | 9.4 | 0.5 | 0 | 7 | 6 | 0 | Autosomal recessive polycystic kidney disease (ARPKD) | 10 | 7.2 | 0.4 | 3 | 6 | 0 | 1 | Dysplastic cystic kidney | 7 | 5 | 0.2 | 1 | 3 | 2 | 1 | Steroid resistant nephrotic syndrome (congenital & childhood) | 5 | 3.6 | 0.2 | 4 | 1 | 0 | 0 | Primary hyperoxaluria | 5 | 3.6 | 0.2 | 2 | 2 | 1 | 0 | Prune-belly syndrome | 5 | 3.6 | 0.2 | 2 | 2 | 1 | 0 | Familial focal segmental glomerulosclerosis | 5 | 3.6 | 0.2 | 1 | 2 | 2 | 0 | Medullary cystic kidney | 4 | 2.9 | 0.1 | 3 | 0 | 1 | 0 | Familial interstitial nephropathy | 2 | 1.4 | 0.1 | 1 | 1 | 0 | 0 | Haemolytic uremic syndrome | 2 | 1.4 | 0.1 | 2 | 0 | 0 | 0 | Mesangioproliferative glomerulosclerosis | 2 | 1.4 | 0.1 | 0 | 1 | 1 | 0 | Membranoproliferative glomerulosclerosis | 2 | 1.4 | 0.1 | 0 | 0 | 0 | 2 | Nephronophthisis | 1 | 0.7 | 0 | 1 | 0 | 0 | 0 | Bartter syndrome | 1 | 0.7 | 0 | 0 | 1 | 0 | 0 | Lowe's syndrome | 1 | 0.7 | 0 | 0 | 1 | 0 | 0 | Renal tubular acidosis | 1 | 0.7 | 0 | 0 | 1 | 0 | 0 | Undetermined familial disease | 1 | 0.7 | 0 | 1 | 0 | 0 | 0 |
| Total | 139 | 100% | 5% | 30 | 35 | 33 | 36 |
|
|